Groupe la Francaise’s scPharmaceuticals SCPH Stock Holding History

Groupe la Francaise’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-240,000	Closed	-$1.36M	–	728
2025 Q3	$1.36M	Buy	+240,000	New	+$1.23M	0.02%	279

Groupe la Francaise's SCPH Position: Q4 2025 in Review

Groupe la Francaise sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 240,000 shares — an estimated $1.36M sold.

Groupe la Francaise first reported a position in SCPH in Q3 2025 and held it in 1 quarter. The position peaked at $1.36M in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Groupe la Francaise reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Groupe la Francaise sold 240,000 scPharmaceuticals shares in Q4 2025, an estimated $1.36M.
Groupe la Francaise first reported a position in scPharmaceuticals in Q3 2025 and held it in 1 quarter.
Groupe la Francaise's scPharmaceuticals position peaked at $1.36M in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Groupe la Francaise's 13F filing for Q4 2025, filed 12 Feb 2026.